Robert Bessler sold $856k of LFST
director at LifeStance Health Group, Inc.. 121,643 shares at an average of $7.04, traded Dec 19, 2025, filed Dec 23, 2025.
Score components
- +15RoleDirector
- +23Trade size$856k at market
- 0Share of holdings soldSold 8.8% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +4.4%, 3m -8.6%, 6m +33.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-331253, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 19, 2025 | SOpen-market sale Common Stockindirect: Vitthal LLC10b5-1 | -59,971 | $7.04 | $422k | 1,318,983 | Dec 23, 2025 |
| Dec 19, 2025 | SOpen-market sale Common Stockindirect: Shama LLC10b5-1 | -59,971 | $7.04 | $422k | 1,435,783 | Dec 23, 2025 |
| Dec 22, 2025 | SOpen-market sale Common Stockindirect: Vitthal LLC10b5-1 | -850 | $7.04 | $5,984 | 1,318,133 | Dec 23, 2025 |
| Dec 22, 2025 | SOpen-market sale Common Stockindirect: Shama LLC10b5-1 | -851 | $7.04 | $5,991 | 1,434,932 | Dec 23, 2025 |
Related signals
Other insiders at LifeStance Health Group, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | LifeStance Health Group, Inc. | Tpg Gp A, LLC owner | $226M 18,409,705 shares | -19% | |
| 47Moderate | LifeStance Health Group, Inc. | Vukasin Paunovich Chief Technology Officer | $541k 42,067 shares | -17% | |
| 40Moderate | LifeStance Health Group, Inc. | Teresa DeLuca director | $95k 7,500 shares | -7% | |
| 48Moderate | LifeStance Health Group, Inc. | Teresa DeLuca director | $250k 20,441 shares | -16% | |
| 60Notable | LifeStance Health Group, Inc. | Kenneth A Burdick Chief Executive Officer | $5.8M 500,000 shares | -14% | |
| 57Moderate | LifeStance Health Group, Inc. | Tpg Gp A, LLC owner | $145M 13,643,207 shares | -12% | |
| 38Weak | LifeStance Health Group, Inc. | Lisa K Miller Chief Operating Officer | $520k 47,912 shares | -15% | |
| 33Weak | LifeStance Health Group, Inc. | Vukasin Paunovich Chief Technology Officer | $482k 44,394 shares | -15% | |
| 40Moderate | LifeStance Health Group, Inc. | Robert Bessler director | $9.1M 894,337 shares | -91% | |
| 60Notable | LifeStance Health Group, Inc. | Darren M. Black director | $47M 5,899,661 shares | -20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.